These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26132584)

  • 1. The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.
    Sachdeva KS; Raizada N; Gupta RS; Nair SA; Denkinger C; Paramasivan CN; Kulsange S; Thakur R; Dewan P; Boehme C; Arinaminpathy N
    PLoS One; 2015; 10(7):e0131438. PubMed ID: 26132584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease control implications of India's changing multi-drug resistant tuberculosis epidemic.
    Suen SC; Bendavid E; Goldhaber-Fiebert JD
    PLoS One; 2014; 9(3):e89822. PubMed ID: 24608234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
    Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
    PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model.
    Salje H; Andrews JR; Deo S; Satyanarayana S; Sun AY; Pai M; Dowdy DW
    PLoS Med; 2014 Jul; 11(7):e1001674. PubMed ID: 25025235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug sensitivity patterns in Xpert-positive spinal tuberculosis: an observational study of 252 patients.
    Upadhyay M; Patel J; Kundnani V; Ruparel S; Patel A
    Eur Spine J; 2020 Jul; 29(7):1476-1482. PubMed ID: 32055960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
    Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
    BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations.
    Talbot EA; Pai M
    Int J Tuberc Lung Dis; 2019 Jul; 23(7):774-782. PubMed ID: 31439108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India.
    Nair D; Navneethapandian PD; Tripathy JP; Harries AD; Klinton JS; Watson B; Sivaramakrishnan GN; Reddy DS; Murali L; Natrajan M; Swaminathan S
    Trans R Soc Trop Med Hyg; 2016 Sep; 110(9):534-541. PubMed ID: 27738284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of tuberculosis drug resistance among Tibetan refugees in India.
    Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.
    Jain A; Singh PK; Chooramani G; Dixit P; Malhotra HS
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):870-5. PubMed ID: 27287637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
    Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis.
    Dowdy DW; van't Hoog A; Shah M; Cobelens F
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):647-54. PubMed ID: 24903933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.
    Udwadia ZF; Tornheim JA; Ganatra S; DeLuca A; Rodrigues CS; Gupta A
    BMC Infect Dis; 2019 Jan; 19(1):94. PubMed ID: 30691407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
    Kassa GM; Merid MW; Muluneh AG; Wolde HF
    PLoS One; 2021; 16(2):e0246938. PubMed ID: 33600409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.